<DOC>
	<DOCNO>NCT00509470</DOCNO>
	<brief_summary>The purpose study compare depressor effect safety combination therapy telmisartan plus low-dose hydrochlorothiazide amlodipine hypertensive patient .</brief_summary>
	<brief_title>Evaluation Effect Combination With Telmisartan Hydrochlorothiazide Hypertensives Uncontrolled Amlodipine</brief_title>
	<detailed_description>In hypertensive patient whose blood pressure ( BP ) reach less 140/90 mmHg 5mg/day amlodipine divide follow two group BP response , laboratory data , adverse effect compare . Group 1 : 12 week combination therapy telmisartan plus low-dose hydrochlorothiazide . Group 2 : Amlodipine continuously administer .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>5 mg/day amlodipine administer 3 month Systolic diastolic blood pressure &gt; = 140/90 mmHg ( 2 time measurement outpatient clinic start study ) Outpatients Secondary hypertension include renovascular hypertension single kidney bilateral stenosis Administration antihypertensives amlodipine Cardiovascular disease ( cerebral hemorrhage , cerebral infarction , TIA , angina , myocardial infarction , acute renal failure ) occur less 6 month start study Serum creatinine &gt; = 2.0 mg/dl Severe hypertension ( systolic diastolic blood pressure &gt; = 180/110 mmHg ) malignant hypertension ( hypertensive organ damage rapidly develop ) Chronic heart failure ( NYHA class &gt; =III VI ) Contraindication telmisartan hydrochlorothiazide Hyper ( &gt; = 5.5 mEq/L ) hypo ( &lt; =3.5 mEq/l ) potassemia Untreated hyperuricemia uncontrolled hyperuricemia ( serum uric acid &gt; = 8.0 mg/dl ) Diabetic patient require insulin therapy , uncontrolled diabetic patient ( hemoglobin A1c &gt; =9.0 % ) , patient possess risk hypoglycemic attack Patients inadequate study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>